ACADIA PHARMACEUTICALS INC (ACAD)
US0042251084 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to ACAD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 30.21. This target is 77.42% above the current price.
ACAD was analyzed by 27 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about ACAD.
In the previous month the buy percentage consensus was at a similar level.
ACAD was analyzed by 27 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-04-09 | Needham | Reiterate | Buy -> Buy |
| 2024-03-25 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-03-13 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-03-12 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-03-12 | Mizuho | Downgrade | Buy -> Neutral |
| 2024-03-12 | JMP Securities | Maintains | Outperform -> Outperform |
| 2024-03-12 | Needham | Maintains | Buy -> Buy |
| 2024-03-12 | Oppenheimer | Maintains | Perform -> Perform |
| 2024-03-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-03-12 | Baird | Maintains | Outperform -> Outperform |
| 2024-03-12 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-12 | B of A Securities | Maintains | Neutral -> Neutral |
| 2024-03-12 | Citigroup | Maintains | Buy -> Buy |
| 2024-03-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-01 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-28 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-02-28 | Mizuho | Maintains | Buy -> Buy |
| 2024-02-28 | Needham | Maintains | Buy -> Buy |
| 2024-02-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-07 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-02-05 | Oppenheimer | Reiterate | Perform -> Perform |
| 2024-02-02 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-01-30 | Baird | Initiate | Outperform |
| 2024-01-24 | Needham | Upgrade | Hold -> Buy |
| 2023-12-29 | Mizuho | Maintains | Buy -> Buy |
| 2023-12-19 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2023-12-18 | Stifel | Maintains | Hold -> Hold |
| 2023-12-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |